Putnam Investments LLC Enanta Pharmaceuticals Inc Transaction History

Putnam Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$11.09 - $22.13 $2,827 - $5,643	-255 Reduced 0.86%	29,501 $329,000
Q2 2023 Aug 14, 2023	SELL	$20.68 - $39.85 $19,211 - $37,020	-929 Reduced 3.03%	29,756 $636,000
Q1 2023 May 22, 2023	SELL	$38.82 - $54.59 $50,427 - $70,912	-1,299 Reduced 4.06%	30,685 $1.24 Million
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $733 - $967	-18 Reduced 0.06%	31,984 $1.49 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $531,238 - $784,041	-11,001 Reduced 25.58%	32,002 $1.66 Million
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $621,252 - $1.25 Million	16,293 Added 61.0%	43,003 $2.03 Million
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $113,577 - $150,146	-2,026 Reduced 7.05%	26,710 $1.9 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $1.73 Million - $2.8 Million	28,736 New	28,736 $2.15 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.